Module 1: Medication Treatment for Opioid Disorders
This module offers quick, targeted information on how to get started offering OUD treatment medications and other recovery support services in your practice. Learn about the science behind it, hear how your peers have implemented it, find resources to get started, and propose a topic for the next Science to Medicine series.
This activity is intended for physicians, physician assistants, pharmacists, registered nurses, nurse practitioners/other APRN and dentists engaged in the care of patients with substance use disorder/addiction in emergency medicine, federally qualified health center, inpatient hospital, pediatric/adolescent medicine, primary care, pain management, dental, family medicine/obstetrics, or pharmacy settings.
After completing this activity, the participant should be better able to:
- Describe recent peer-reviewed research about medication treatment for opioid use disorder; screening for substance use; providing naloxone in the pharmacy setting; managing patients’ pain.
- Demonstrate when and how screening for substance use should occur.
- Identify appropriate substance use screening and assessment tools.
- Explain next steps to take after receiving a positive screen from a patient.
- Explain strategies to patients, families, and colleagues about how to begin medication treatment for opioid use disorder.
- Practice how to provide medication treatment for opioid use disorder in your practice.
- Describe medications to treat patients with opioid use disorder.
- Explain the importance of naloxone distribution by pharmacists.
- Develop steps to identify people at risk of overdose and explain how naloxone distribution can be implemented in the pharmacy setting.
- Evaluate pain treatment options that will be appropriate for patients.
Assistant Professor of Emergency Medicine
Professor of Physician Assistant Studies
The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The George Washington University School of Medicine and Health Sciences designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.